tiprankstipranks
Vertex Pharmaceuticals price target raised to $424 from $417 at RBC Capital
PremiumThe FlyVertex Pharmaceuticals price target raised to $424 from $417 at RBC Capital
9d ago
Vertex Pharmaceuticals price target raised to $456 from $450 at Piper Sandler
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $456 from $450 at Piper Sandler
9d ago
Vertex Pharmaceuticals affirms FY4 revenue view of $10.55B-$10.75B
PremiumThe Fly
Vertex Pharmaceuticals affirms FY4 revenue view of $10.55B-$10.75B
10d ago
VRTX Earnings this Week: How Will it Perform?
PremiumPre-EarningsVRTX Earnings this Week: How Will it Perform?
12d ago
Vertex announces European Commission approval for KALYDECO
PremiumThe Fly
Vertex announces European Commission approval for KALYDECO
20d ago
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
20d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
1M ago
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
PremiumThe Fly
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100